谷歌浏览器插件
订阅小程序
在清言上使用

CML-413: Asciminib Provides Durable Responses and a Favorable Safety Profile in Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) with the T315I Mutation in a Phase 1 Study

Clinical Lymphoma Myeloma & Leukemia(2021)

引用 0|浏览0
暂无评分
关键词
CML,T315I,asciminib
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要